Protocol for the Stimulating β3-Adrenergic Receptors for Peripheral Artery Disease (STAR-PAD) trial: a double-blinded, randomised, placebo-controlled study evaluating the effects of mirabegron on functional performance in patients with peripheral arterial disease.

Kristen J BubbJason A HarmerMeghan FinemoreSarah Joy AitkenZara S AliLaurent BillotClara ChowSamuel L SmithRebecca MisterMichael P GrayStuart M GrieveNaomi HamburgAnthony C KeechSanjay PatelVikram PuttaswamyGemma A Figtree

Published in: BMJ open (2021)

ACTRN12619000423112; Results.

Keyphrases

peripheral artery disease
double blind
phase iii
study protocol
clinical trial
phase ii
placebo controlled
randomized controlled trial
open label